Therapure launches custom biologics offering
Therapure Biopharma says ‘long history’ of product development will help it compete in the custom biologics manufacturing sector.
Archives for April 24, 2012
Amgen warns biosimilar draft a threat to production innovation
Amgen has told the FDA that draft biosimilar guidance risks inhibiting manufacturing improvements and burdening industry.